Skip to main content
Search hero banner

Search results

Showing 701 - 720 of 1126 results

Unsung Aussie Net Zero Hero

Australia’s Nuclear Science and Technology Organisation (ANSTO) is well-known for facilitating incredible science and creating life-saving nuclear medicines, but for the last 40 years it’s been quietly producing a largely unsung net zero hero: Neutron Transmutation Doped (NTD) silicon.

coming to visit lucasheights ansto

Visit our Sydney facilities

ANSTO's Sydney locations are home to the Open Pool Australian Light-water (OPAL) multi-purpose reactor, the Centre for Accelerator Science (CAS), the Australian Centre for Neutron Scattering, the National Research Cyclotron and the National Deuteration Facility.

bruised hand

Identification and analysis of components in bruises

As blood breaks down in the skin tissue, the colour of a bruise changes with time. As such, it may be used to find out information about the age of the bruise and hence a timeframe of when the incident that caused the mark took place.

After your experiment

After your experiment

Following your experiment at ANSTO there are certain tasks that users can complete including a user feedback survey and claiming reimbursement for travel expenses.

New partnership

Australia and Sri Lanks signs new partnership to fight chronic kidney disease.

IAEA appointment

ANSTO Head of Research Dr Suzanne Hollins has been appointed to chair IAEA group on nuclear applications.

Research on nickel

Study reveals that properties of polycrystalline materials can be derived from microscopic single crystal samples

Picture of detector

Radiation Monitoring

ANSTO continually monitors environmental gamma radiation from a station located in Engadine NSW. ANSTO uses environmental radiation data to evaluate atmospheric dispersion from its site. This radiation is almost completely natural background radiation.

ANSTO helping to ensure the safety of astronauts in space

A team of ANSTO health researchers, staff at the Centre for Accelerator Science and Dr Melanie Ferlazzo, a postdoc from the French National Institute of Health and Medical Research (INSERM), and scientists from the French Space Agency (CNES), are collaborating on investigations to determine the impact of secondary particles on human cells using the new microprobe beamline at ANSTO’s Centre for Accelerator Science.

Pagination